• Live Feeds
    • Press Releases
    • Insider Trading
    • FDA Approvals
    • Analyst Ratings
    • Insider Trading
    • SEC filings
    • Market insights
  • Analyst Ratings
  • Alerts
  • Subscriptions
  • Settings
  • RSS Feeds
Quantisnow Logo
  • Live Feeds
    • Press Releases
    • Insider Trading
    • FDA Approvals
    • Analyst Ratings
    • Insider Trading
    • SEC filings
    • Market insights
  • Analyst Ratings
  • Alerts
  • Subscriptions
  • Settings
  • RSS Feeds
Dashboard
    Quantisnow Logo

    © 2025 quantisnow.com
    Democratizing insights since 2022

    Services
    Live news feedsRSS FeedsAlerts
    Company
    AboutQuantisnow PlusContactJobs
    Legal
    Terms of usePrivacy policyCookie policy

    Update: Annual Changes to the Nasdaq-100® Index

    12/12/23 6:00:00 PM ET
    $NDAQ
    $PFE
    $SGEN
    $TTWO
    Investment Bankers/Brokers/Service
    Finance
    Biotechnology: Pharmaceutical Preparations
    Health Care
    Get the next $NDAQ alert in real time by email

    NEW YORK, Dec. 12, 2023 (GLOBE NEWSWIRE) -- Nasdaq (NASDAQ:NDAQ) today announced an update to the annual reconstitution of the Nasdaq-100 Index® (NASDAQ:NDX). Per the announcement by Pfizer Inc. (NYSE:PFE), the pending acquisition of Seagen, Inc. (NASDAQ:SGEN) is expected to close on December 14, 2023. As a result, Take-Two Interactive Software, Inc. (NASDAQ:TTWO), will be added to the Nasdaq-100 Index® and Seagen, Inc. will be removed as part of the annual reconstitution, which will become effective prior to market open on Monday, December 18, 2023.

    The other constituent changes from the initial announcement by Nasdaq on Friday, December 8, 2023, will remain the same.

    Information

    For information about the company being added to the Nasdaq-100 Index® per this update, please visit the company website: Take-Two Interactive Software, Inc. – https://www.take2games.com/.

    About Nasdaq Global Indexes

    Nasdaq Global Indexes has been creating innovative, market-leading, transparent indexes since 1971. Today, our index offering spans geographies and asset classes and includes diverse families such as the Dividend and Income (includes Dividend Achievers), Nasdaq Dorsey Wright, Fixed Income (includes BulletShares®), Global Equity, Green Economy, Nordic, and Commodity indexes. We continuously offer new opportunities for financial product sponsors across a wide spectrum of investable products and for asset managers to measure risk and performance. Nasdaq also provides exchange listing, custom index, and design solutions to financial organizations worldwide.

    About Nasdaq

    Nasdaq (NASDAQ:NDAQ) is a leading global technology company serving corporate clients, investment managers, banks, brokers, and exchange operators as they navigate and interact with the global capital markets and the broader financial system. We aspire to deliver world-leading platforms that improve the liquidity, transparency, and integrity of the global economy. Our diverse offering of data, analytics, software, exchange capabilities, and client-centric services enables clients to optimize and execute their business vision with confidence. To learn more about the company, technology solutions, and career opportunities, visit us on LinkedIn, on X @Nasdaq, or at www.nasdaq.com.

    The information contained above is provided for informational and educational purposes only, and nothing contained herein should be construed as investment advice, either on behalf of a particular financial product or an overall investment strategy. Neither The Nasdaq OMX Group, Inc. nor any of its affiliates makes any recommendation to buy or sell any financial product or any representation about the financial condition of any company or fund. Statements regarding Nasdaq's proprietary indexes are not guarantees of future performance. Actual results may differ materially from those expressed or implied. Past performance is not indicative of future results. Investors should undertake their own due diligence and carefully evaluate companies before investing. ADVICE FROM A SECURITIES PROFESSIONAL IS STRONGLY ADVISED.

    - NDAQG -

    Media Relations ContactsInvestor Relations Contact  
    Name: Camille StaffordName: Index Client Services  
    Email: [email protected]

    Email  [email protected]  
      
    Name: Jennifer Lawson 
    Email: [email protected] 
      


    Primary Logo

    Get the next $NDAQ alert in real time by email

    Chat with this insight

    Save time and jump to the most important pieces.

    Recent Analyst Ratings for
    $NDAQ
    $PFE
    $SGEN
    $TTWO

    CompanyDatePrice TargetRatingAnalyst
    Pfizer Inc.
    $PFE
    4/22/2025$24.00Neutral
    Cantor Fitzgerald
    Nasdaq Inc.
    $NDAQ
    4/17/2025$91.00Neutral → Buy
    Redburn Atlantic
    Nasdaq Inc.
    $NDAQ
    4/8/2025$74.00Overweight → Equal-Weight
    Morgan Stanley
    Take-Two Interactive Software Inc.
    $TTWO
    2/19/2025$250.00Buy
    DA Davidson
    Take-Two Interactive Software Inc.
    $TTWO
    1/27/2025$175.00 → $230.00Buy → Neutral
    UBS
    Take-Two Interactive Software Inc.
    $TTWO
    1/27/2025$175.00 → $230.00Neutral → Buy
    UBS
    Nasdaq Inc.
    $NDAQ
    1/8/2025$80.00 → $98.00Hold → Buy
    Deutsche Bank
    Take-Two Interactive Software Inc.
    $TTWO
    12/11/2024$200.00 → $225.00Buy
    Citigroup
    More analyst ratings

    $NDAQ
    $PFE
    $SGEN
    $TTWO
    Press Releases

    Fastest customizable press release news feed in the world

    See more
    • Shopify Inc to Join the Nasdaq-100 Index® Beginning May 19, 2025

      NEW YORK, May 09, 2025 (GLOBE NEWSWIRE) -- Nasdaq (NASDAQ:NDAQ) today announced that Shopify Inc. (NASDAQ:SHOP), will become a component of the Nasdaq-100 Index® (NASDAQ:NDX®) and the Nasdaq-100 Equal Weighted™ Index (NASDAQ:NDXE) prior to market open on Monday, May 19, 2025. Shopify Inc. will replace MongoDB, Inc. (NASDAQ:MDB) in the Nasdaq-100 Index® and the Nasdaq-100 Equal Weighted™ Index. MongoDB, Inc. will also be removed from the Nasdaq-100 Tech Sector™ Index (NASDAQ:NDXT), the Nasdaq-100 Technology Sector Market-Cap Weighted™ Index (NDXTMC™), the Nasdaq-100 Technology Sector Adjusted Market-Cap Weighted™ Index (NDXT10™), the Nasdaq-100 ESG™ Index (NASDAQ:NDXESG), the Nasdaq-100

      5/9/25 8:00:00 PM ET
      $MDB
      $NDAQ
      $SHOP
      Computer Software: Prepackaged Software
      Technology
      Investment Bankers/Brokers/Service
      Finance
    • Nasdaq Announces End-of-Month Open Short Interest Positions in Nasdaq Stocks as of Settlement Date April 30, 2025

      NEW YORK, May 09, 2025 (GLOBE NEWSWIRE) -- At the end of the settlement date of April 30, 2025, short interest in 3,156 Nasdaq Global MarketSM securities totaled 13,300,707,903 shares compared with 13,211,633,004 shares in 3,143 Global Market issues reported for the prior settlement date of April 15, 2025. The mid-April short interest represents 2.40 days compared with 1.76 days for the prior reporting period. Short interest in 1,636 securities on The Nasdaq Capital MarketSM totaled 2,645,060,429 shares at the end of the settlement date of April 30, 2025, compared with 2,609,354,721 shares in 1,634 securities for the previous reporting period. This represents a 1.00 day average daily vo

      5/9/25 4:05:00 PM ET
      $NDAQ
      Investment Bankers/Brokers/Service
      Finance
    • Mafia: The Old Country Launching August 8, 2025; Debuts Official Gameplay Trailer and Developer Insights Video

      Hangar 13 development team to host panel at PAX East to dive into the next chapter of the proven franchise; available now for pre-order Today, 2K and Hangar 13 unveiled the Official Gameplay Trailer and ‘Breaking Omerta' Developer Insights video for Mafia: The Old Country, coming to PlayStation®5 (PS5®), Xbox Series X|S, and PC via Steam and NVIDIA GeForce NOW on August 8, 2025. Fans can watch the PAX East developer panel today at 2:00 p.m. EDT on YouTube and Twitch to learn about Mafia: The Old Country directly from its developers, and to pre-order the game today. This press release features multimedia. View the full release here: https://www.businesswire.com/news/home/20250508930640/en/T

      5/8/25 11:00:00 AM ET
      $TTWO
      Computer Software: Prepackaged Software
      Technology

    $NDAQ
    $PFE
    $SGEN
    $TTWO
    Leadership Updates

    Live Leadership Updates

    See more
    • Shopify Inc to Join the Nasdaq-100 Index® Beginning May 19, 2025

      NEW YORK, May 09, 2025 (GLOBE NEWSWIRE) -- Nasdaq (NASDAQ:NDAQ) today announced that Shopify Inc. (NASDAQ:SHOP), will become a component of the Nasdaq-100 Index® (NASDAQ:NDX®) and the Nasdaq-100 Equal Weighted™ Index (NASDAQ:NDXE) prior to market open on Monday, May 19, 2025. Shopify Inc. will replace MongoDB, Inc. (NASDAQ:MDB) in the Nasdaq-100 Index® and the Nasdaq-100 Equal Weighted™ Index. MongoDB, Inc. will also be removed from the Nasdaq-100 Tech Sector™ Index (NASDAQ:NDXT), the Nasdaq-100 Technology Sector Market-Cap Weighted™ Index (NDXTMC™), the Nasdaq-100 Technology Sector Adjusted Market-Cap Weighted™ Index (NDXT10™), the Nasdaq-100 ESG™ Index (NASDAQ:NDXESG), the Nasdaq-100

      5/9/25 8:00:00 PM ET
      $MDB
      $NDAQ
      $SHOP
      Computer Software: Prepackaged Software
      Technology
      Investment Bankers/Brokers/Service
      Finance
    • Dexcom Appoints Jon Coleman as Chief Commercial Officer

      DexCom, Inc. (NASDAQ:DXCM), the global leader in glucose biosensing, today announced the appointment of Jon Coleman as chief commercial officer. In this role, Mr. Coleman will assume responsibility for Dexcom's global commercial organization, including global sales, marketing and customer experience. Mr. Coleman joins Dexcom with more than 30 years of global commercial leadership experience across multiple healthcare segments and channels. Mr. Coleman served as an executive officer of Masimo Corporation (NASDAQ:MASI), where he held roles of increasing responsibility across his fifteen-year tenure. This included serving as president of Masimo's commercial teams where he oversaw the consolid

      3/25/25 4:05:00 PM ET
      $DXCM
      $MASI
      $PFE
      Medical/Dental Instruments
      Health Care
      Biotechnology: Electromedical & Electrotherapeutic Apparatus
      Biotechnology: Pharmaceutical Preparations
    • Nasdaq Appoints Brandis DeSimone as New Head of East Coast Listings

      The appointment strengthens Nasdaq's commitment to supporting companies throughout their corporate lifecycle Nasdaq is the exchange of choice for new listings and exchange transfers in the US, raising $22.97 Billion in IPO proceeds across 180 listings in 2024 and celebrating over 500 transfers to Nasdaq since 2005 NEW YORK, March 03, 2025 (GLOBE NEWSWIRE) -- Nasdaq (NASDAQ:NDAQ) today announced the appointment of Brandis DeSimone as Senior Vice President, Head of East Coast Listings. Under the recently established regional operational structure, this appointment further strengthens Nasdaq's commitment to supporting companies throughout their corporate lifecycle and deepening client rel

      3/3/25 10:40:42 AM ET
      $NDAQ
      Investment Bankers/Brokers/Service
      Finance

    $NDAQ
    $PFE
    $SGEN
    $TTWO
    Insider Trading

    Insider transactions reveal critical sentiment about the company from key stakeholders. See them live in this feed.

    See more
    • SEC Form 4 filed by Chairman & CEO Bourla Albert

      4 - PFIZER INC (0000078003) (Issuer)

      5/2/25 1:35:56 PM ET
      $PFE
      Biotechnology: Pharmaceutical Preparations
      Health Care
    • SEC Form 4 filed by Director Nora Johnson Suzanne M

      4 - PFIZER INC (0000078003) (Issuer)

      4/28/25 11:55:19 AM ET
      $PFE
      Biotechnology: Pharmaceutical Preparations
      Health Care
    • SEC Form 4 filed by Director Blaylock Ronald E

      4 - PFIZER INC (0000078003) (Issuer)

      4/28/25 11:55:18 AM ET
      $PFE
      Biotechnology: Pharmaceutical Preparations
      Health Care

    $NDAQ
    $PFE
    $SGEN
    $TTWO
    SEC Filings

    See more
    • Amendment: SEC Form SCHEDULE 13D/A filed by Nasdaq Inc.

      SCHEDULE 13D/A - NASDAQ, INC. (0001120193) (Subject)

      5/9/25 5:31:45 PM ET
      $NDAQ
      Investment Bankers/Brokers/Service
      Finance
    • SEC Form 10-Q filed by Pfizer Inc.

      10-Q - PFIZER INC (0000078003) (Filer)

      5/5/25 4:00:34 PM ET
      $PFE
      Biotechnology: Pharmaceutical Preparations
      Health Care
    • Take-Two Interactive Software Inc. filed SEC Form 8-K: Regulation FD Disclosure, Financial Statements and Exhibits

      8-K - TAKE TWO INTERACTIVE SOFTWARE INC (0000946581) (Filer)

      5/2/25 7:34:20 AM ET
      $TTWO
      Computer Software: Prepackaged Software
      Technology

    $NDAQ
    $PFE
    $SGEN
    $TTWO
    Large Ownership Changes

    This live feed shows all institutional transactions in real time.

    See more
    • Amendment: SEC Form SC 13G/A filed by Nasdaq Inc.

      SC 13G/A - NASDAQ, INC. (0001120193) (Subject)

      11/12/24 3:53:01 PM ET
      $NDAQ
      Investment Bankers/Brokers/Service
      Finance
    • SEC Form SC 13G filed by Nasdaq Inc.

      SC 13G - NASDAQ, INC. (0001120193) (Subject)

      11/8/24 10:52:39 AM ET
      $NDAQ
      Investment Bankers/Brokers/Service
      Finance
    • Amendment: SEC Form SC 13G/A filed by Nasdaq Inc.

      SC 13G/A - NASDAQ, INC. (0001120193) (Subject)

      11/4/24 1:18:47 PM ET
      $NDAQ
      Investment Bankers/Brokers/Service
      Finance

    $NDAQ
    $PFE
    $SGEN
    $TTWO
    Insider Purchases

    Insider purchases reveal critical bullish sentiment about the company from key stakeholders. See them live in this feed.

    See more
    • Director Blaylock Ronald E bought $499,072 worth of shares (19,457 units at $25.65), increasing direct ownership by 236% to 27,707 units (SEC Form 4)

      4 - PFIZER INC (0000078003) (Issuer)

      2/14/25 5:16:36 PM ET
      $PFE
      Biotechnology: Pharmaceutical Preparations
      Health Care
    • Director Zollar Alfred W bought $203,970 worth of shares (2,542 units at $80.24), increasing direct ownership by 5% to 49,293 units (SEC Form 4)

      4 - NASDAQ, INC. (0001120193) (Issuer)

      11/14/24 4:29:16 PM ET
      $NDAQ
      Investment Bankers/Brokers/Service
      Finance
    • Director Gottlieb Scott bought $28,240 worth of shares (1,000 units at $28.24), increasing direct ownership by 11% to 10,000 units (SEC Form 4)

      4 - PFIZER INC (0000078003) (Issuer)

      10/31/24 4:06:54 PM ET
      $PFE
      Biotechnology: Pharmaceutical Preparations
      Health Care

    $NDAQ
    $PFE
    $SGEN
    $TTWO
    Financials

    Live finance-specific insights

    See more
    • Take-Two Interactive Software, Inc. Reiterates Expectations to Achieve Sequential Increases in, and Record Levels of, Net Bookings in Fiscal 2026 and 2027

      Rockstar Games announces release date for Grand Theft Auto VI of May 26, 2026 Company to report its fourth quarter and Fiscal 2025 results on May 15, 2025 Take-Two Interactive Software, Inc. (NASDAQ:TTWO) today reiterated its expectations that the Company will achieve sequential increases in, and record levels of, Net Bookings in Fiscal 2026 and 2027. In addition, Take-Two's wholly-owned label, Rockstar Games, has announced that Grand Theft Auto VI, which was expected to launch in Fall of 2025, is now planned for release on May 26, 2026, during the Company's Fiscal Year 2027. "We support fully Rockstar Games taking additional time to realize their creative vision for Grand Theft Auto VI,

      5/2/25 7:30:00 AM ET
      $TTWO
      Computer Software: Prepackaged Software
      Technology
    • Pfizer Reports Solid First-Quarter 2025 Results And Reaffirms 2025 Guidance

      Delivers Robust Earnings Performance, Successfully Navigating a Dynamic Environment Made Significant Progress Strengthening the R&D Organization On Track to Exceed Net Cost Savings Targets Pfizer Inc. (NYSE:PFE) reported financial results for the first quarter of 2025 and reaffirmed its 2025 financial guidance(1). EXECUTIVE COMMENTARY Dr. Albert Bourla, Chairman and CEO of Pfizer: "We continued to execute with focus and discipline against our strategic priorities, including strengthening our R&D organization and driving improved productivity. With the underlying strength of our business, we believe we can be agile in navigating an uncertain and volatile external environment." Dav

      4/29/25 6:45:00 AM ET
      $PFE
      Biotechnology: Pharmaceutical Preparations
      Health Care
    • Nasdaq Announces 13% Increase in Quarterly Dividend to $0.27 Per Share

      NEW YORK, April 24, 2025 (GLOBE NEWSWIRE) -- The Board of Directors of Nasdaq, Inc. (NASDAQ:NDAQ) has declared a regular quarterly dividend of $0.27 per share on the company's outstanding common stock, a 13% increase from the previous quarter. The dividend is payable on June 27, 2025 to shareholders of record at the close of business on June 13, 2025. Future declarations of quarterly dividends and the establishment of future record and payment dates are subject to approval by the Board of Directors. About Nasdaq Nasdaq (NASDAQ:NDAQ) is a leading global technology company serving corporate clients, investment managers, banks, brokers, and exchange operators as they navigate and intera

      4/24/25 7:01:00 AM ET
      $NDAQ
      Investment Bankers/Brokers/Service
      Finance

    $NDAQ
    $PFE
    $SGEN
    $TTWO
    FDA approvals

    Live FDA approvals issued by the Food and Drug Administration and FDA breaking news

    See more
    • October 25, 2024 - FDA Roundup: October 25, 2024

      For Immediate Release: October 25, 2024 Today, the U.S. Food and Drug Administration is providing an at-a-glance summary of news from around the agency:  Today, the FDA updated the advisory for the outbreak of E. coli O157:H7. A specific ingredient has not yet been confirmed as the source of the outbreak, but most sick people report eating McDonald’s Quarter Pounder burgers. Investigators are working to deter

      10/25/24 2:48:21 PM ET
      $PFE
      Biotechnology: Pharmaceutical Preparations
      Health Care
    • FDA Approval for HYMPAVZI issued to PFIZER INC

      Submission status for PFIZER INC's drug HYMPAVZI (ORIG-1) with active ingredient MARSTACIMAB-HNCQ has changed to 'Approval' on 10/11/2024. Application Category: BLA, Application Number: 761369, Application Classification:

      10/15/24 2:57:27 PM ET
      $PFE
      Biotechnology: Pharmaceutical Preparations
      Health Care
    • October 11, 2024 - FDA Approves New Treatment for Hemophilia A or B

      For Immediate Release: October 11, 2024 Today, the U.S. Food and Drug Administration approved Hympavzi (marstacimab-hncq) for routine prophylaxis to prevent or reduce the frequency of bleeding episodes in adult and pediatric patients 12 years of age and older with hemophilia A without factor VIII inhibitors or hemophilia B without factor IX inhibitors (neutralizing antibodies). “Today’s approval of Hympavzi pro

      10/11/24 2:12:15 PM ET
      $PFE
      Biotechnology: Pharmaceutical Preparations
      Health Care

    $NDAQ
    $PFE
    $SGEN
    $TTWO
    Analyst Ratings

    Analyst ratings in real time. Analyst ratings have a very high impact on the underlying stock. See them live in this feed.

    See more
    • Cantor Fitzgerald initiated coverage on Pfizer with a new price target

      Cantor Fitzgerald initiated coverage of Pfizer with a rating of Neutral and set a new price target of $24.00

      4/22/25 8:03:45 AM ET
      $PFE
      Biotechnology: Pharmaceutical Preparations
      Health Care
    • NASDAQ upgraded by Redburn Atlantic with a new price target

      Redburn Atlantic upgraded NASDAQ from Neutral to Buy and set a new price target of $91.00

      4/17/25 8:27:31 AM ET
      $NDAQ
      Investment Bankers/Brokers/Service
      Finance
    • NASDAQ downgraded by Morgan Stanley with a new price target

      Morgan Stanley downgraded NASDAQ from Overweight to Equal-Weight and set a new price target of $74.00

      4/8/25 9:21:41 AM ET
      $NDAQ
      Investment Bankers/Brokers/Service
      Finance